MENU
CLDX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Celldex Therapeutics (CLDX) Earnings Date & Reports
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
CLDX is expected to report earnings to fall 11.02% to -104 cents per share on August 06
Q2'26
Est.
$-1.05
Q1'26
Beat
by $0.01
Q4'25
Missed
by $0.21
Q3'25
Missed
by $0.11
Q2'25
Beat
by $0.01
The last earnings report on May 07 showed earnings per share of -117 cents, beating the estimate of -119 cents. With 599.81K shares outstanding, the current market capitalization sits at 2.45B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of immunotherapy technologies for the treatment of cancer and other diseases
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
53 Frontage Road
Phone
+1 908 200-7500
Employees
198
Web
https://www.celldex.com